FindTrial
Sign In

Injection treatment for hip fracture surgery

Single blind randamized control trial comparing injection bupivacaine with dexamethasone versus injection bupivacaine with dexmedetomidine in suprainguinal fascia iliaca block for postoperative pain relief in fracture hip surgery - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099343
Enrollment
40
Registered
2025-12-17
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil Intervention2: Bupivacaine with Dexmedetomidine: Intervention arm:Patient will recieve Injection bupivacaine with dexmedetomidine administered in suprainguinal fascia iliaca bl

Sponsors

MIMER Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing hip surgery under spinal anaesthesia ASA Grade I and II

Exclusion criteria

Exclusion criteria: Patients not willing to participate in study with due consent - Drug allergy to Dexmedatomidine -Patients on B blocker,Heart block -Patients with Psychiatric disorder -Severe cardio-pulmonary disease -severe hepatic,renal disease -Neuromuscular disease

Design outcomes

Primary

MeasureTime frame
postoperative pain intensity and duration of analgesia with time of first rescue analgesic requirment.Timepoint: time of first rescue analgesic requirment.—

Secondary

MeasureTime frame
haemodynamic parameteres,sedation score,total amount of analgesic requirement in first 24 hoursTimepoint: 24 hours postoperative period—

Countries

India

Contacts

Public ContactDr Megha Sonawane
drmeghasonavane@gmail.com9158104000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026